Compare journals
Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Drug Discovery Today: TARGETS
Drug Discovery Today: TARGETS is not currently indexed in Scopus. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 1741-8372Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: No APC data — check the publisher
Not listed in: Web of Science, DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Quick answers
Is Drug Discovery Today: TARGETS indexed in Scopus?
No — it was previously covered by Scopus but its coverage is now inactive/discontinued (2002–2004).
What is the impact factor of Drug Discovery Today: TARGETS?
Drug Discovery Today: TARGETS has no Journal Impact Factor — JIF is published only for journals in the Web of Science Core Collection (SCIE, SSCI, AHCI and ESCI) — and Scopus has not published a current CiteScore for it either. Treat any "impact factor" quoted for this journal elsewhere as unofficial.
Who publishes Drug Discovery Today: TARGETS and what is its ISSN?
Drug Discovery Today: TARGETS is published by Elsevier B.V. Its ISSN is 1741-8372.
Is Drug Discovery Today: TARGETS covered under ONOS in India?
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Is Drug Discovery Today: TARGETS in Web of Science?
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Is Drug Discovery Today: TARGETS open access?
No — it is not registered as an open-access journal in DOAJ or Scopus.
Scopus coverage history
Scopus indexed Drug Discovery Today: TARGETS for 3 years, between 2002 and 2004. Coverage ended in 2004, 22 years ago, and Scopus now lists the title as inactive.
Is it still publishing? OpenAlex lists 70 works and 401 citations for the title. Its most recent paper is from 2004, in line with the end of Scopus coverage in 2004, which suggests the journal stopped publishing around then.
How well cited is Drug Discovery Today: TARGETS? — open metrics via OpenAlex
Drug Discovery Today: TARGETS has an h-index of 12 and a 2-year mean of 0 citations per paper (OpenAlex).
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. Updated 2026-10-14.
Are there integrity warnings for Drug Discovery Today: TARGETS? — indicators, not proof of misconduct
Scopus status: Inactive — coverage ended 2004. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
- Scopus statusInactive — coverage ended 2004
- Retracted papers None recorded
- Problematic Paper Screener flags None flagged
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Official sources & links
Community experience: reader comments on this journal
More from Elsevier B.V.
Elsevier B.V. has 1584 other titles in our data; 1020 are currently indexed in Scopus.
Related journals
8 journalsIndex data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.